Submitted by Anonymous (not verified) on 29 October 2024 - 15:10
Human medicines European public assessment report (EPAR): Zavesca, miglustat, Date of authorisation: 20/11/2002, Date of refusal: 16/06/2009, Revision: 34, Status: Authorised
Source: